7.61
-0.24(-3.06%)
Currency In USD
| Previous Close | 7.85 |
| Open | 8.4 |
| Day High | 9.18 |
| Day Low | 7.29 |
| 52-Week High | 47.4 |
| 52-Week Low | 5.55 |
| Volume | 2.4M |
| Average Volume | 886,229 |
| Market Cap | 16.15M |
| PE | -0.37 |
| EPS | -20.7 |
| Moving Average 50 Days | 14.93 |
| Moving Average 200 Days | 13.67 |
| Change | -0.24 |
If you invested $1000 in Imunon, Inc. (IMNN) 10 years ago, it would be worth $1.06 as of July 31, 2025 at a share price of $7.61. Whereas If you bought $1000 worth of Imunon, Inc. (IMNN) shares 5 years ago, it would be worth $30.75 as of July 31, 2025 at a share price of $7.61.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
GlobeNewswire Inc.
Yesterday at 12:05 PM GMT
Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development o
IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025
GlobeNewswire Inc.
Jul 29, 2025 12:30 PM GMT
LAWRENCEVILLE, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company will host a conference call at 11:00 a.m. ET on T
IMUNON Announces Stock Dividend Boosting Shareholder Value
GlobeNewswire Inc.
Jul 28, 2025 12:05 PM GMT
Stock Dividend Reflects Company’s Confidence in its Phase 3 Study, Long-term Growth Potential, and Dedication to Shareholders LAWRENCEVILLE, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 de